Scientific Opinion on the re-evaluation Tartrazine (E 102)

What was studied

EFSA retained oral ADI of 7.5 mg/kg body weight/day, while noting intolerance may occur in sensitive people within that intake. Food additive safety assessment, not topical cosmetic efficacy or guarantee of skin tolerance. Group mixtures cannot isolate behavioral effects.

Checked against the published abstract on Oct 1, 2026. Source 1 ↗Source 2 ↗